The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs

BMC Pediatrics

Volumn 1, Issue , 2001, Pages

  Barrington, Keith J ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; NITRIC OXIDE; PLACEBO; STEROID; CORTICOSTEROID;

BLINDNESS; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM; CEREBRAL PALSY; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DRUG INDICATION; DRUG USE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; NEUROTOXICITY; NEWBORN; OUTCOMES RESEARCH; PERINATAL DRUG EXPOSURE; PREMATURITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STANDARD; SYSTEMATIC REVIEW; TIME; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; LUNG DISEASE; MORTALITY; SURVIVAL RATE;

ADRENAL CORTEX HORMONES; BRONCHOPULMONARY DYSPLASIA; CEREBRAL PALSY; CHRONIC DISEASE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LUNG DISEASES; NERVOUS SYSTEM DISEASES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 0001362414     PISSN: 14712431     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2431-1-1     Document Type: Review

References (27)

1. Silverman WA, Flynn JT: Overview: a developmental retinopathy reconsidered. In Silverman WA, Flynn JT, Eds, Retinopathy of Prematurity, Blackwell Scientific Publications, Boston, 1985,
2. McDonald AS: Neurological and ophthalmic disorders in children of very low birth weight. Br Med J 1962, 1:895-900
3. Feder HM Jr, Osier C, Maderazo EG: Chloramphenicol: A review of its use in clinical practice. Rev Infect Dis 1981, 3:479-491
4. Menon PA, Thach BT, Smith CH, Landt M, Roberts JL, Hillman RE, Hillman LS: Benzyl alcohol toxicity in a neonatal intensive care unit. Incidence, symptomatology, and mortality. Am J Perinatol 1984, 1:288-292
5. Anderson JM, Cockburn F, Forfar JO, Harkness RA, Kelly RW, Kilshaw B: Neonatal spongioform myelinopathy after restricted application of hexachlorophane skin disinfectant. J Clin Pathol 1981, 34:25-29
6. Barrington KJ, Finer NN: An evaluation of the efficacy of dexamethasone in early bronchopulmonary dysplasia. J Perinatol 1985, 5:26-32
7. Barrington KJ, Finer NN: Treatment of bronchopulmonary dysplasia. A review. Clin Perinatol 1998, 25:177-202
8. Halliday HL, Ehrenkrantz RA: Moderately early (7-14) days postnatal corticosteroids for preventing lung disease in preterm infants (Cochrane Review). In: the Cochrane Library, Issue 1, 2001. Oxford: Update Software.
9. Doyle L, Davis P: Review article: postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function. J Paediatr Child Health 2000, 366(2):101-107
10. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG 3rd, Dillard RG: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999, 104:15-21
11. Jones R, Wincott E, Elbourne D, Grant A: Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics 1995, 96:897-906
12. Avery GB, Fletcher AB, Kaplan M, Brudno DS: Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985, 75:106-111
13. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, et al: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000, 83:F177-181
14. Fitzhardinge PM, Eisen A, Lejtenyi C, metrakos K, Ramsay M: Equelae of early steroid administration to the newborn infant. Pediatr 1974, 53:877-883
15. Subhedar NV, Bennett AJ, Wardle SP, Shaw NJ: More trials on early treatment with corticosteroids are needed. BMJ 2000, 320:941-
16. Y eh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH: Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: A multicenter clinical trial. Pediatrics 1997, 100:E3-
17. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ: Early dexamethasone therapy in preterm infants: a follow up study. Pediatr 1998, 101:E7-
18. Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S, Bader D, Yurman S, Dolfin T, Kuint J, et al: Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1996, 74:F33-37
19. Cummings JJ, D'Eugenio DB, Gross SJ: A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia. N Engl J Med 1989, 320:1505-1510
20. Baden M, Bauer CR, Colle E, Klein G, Taeusch HW, Stern L: A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatr 1972, 50:526-534
21. Vincer MJ, Allen AC: Double blind controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW <1500 grams) who ventilator dependent at 4 weeks of age. Pediatr Res 1998, 43:201A-
22. Guyer B, Hoyert DL, Martin JA, Ventura SJ, MacDorman MF, Strobino DM: Annual summary of vital statistics. 1998. Pediatrics 1999, 104:1229-1246
23. Noble-Jamieson CM, Regev R, Silverman M: Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr 1989, 148:365-367
24. Soll RF: Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease. Pediatr Res 1999, 45:226A-
25. Weiler HA, Paes B, Shah JK, Atkinson SA.: Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev 1997, 47(3):271-286
26. Weichsel ME Jr.: The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards. Ann Neurol 1977, 2:364-366
27. Watterberg KL, Gerdes JS, Gifford KL, Lin HM: Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999, 104:1258-1263